nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Ischaemia—Mitoxantrone—sarcoma	0.0321	0.0321	CcSEcCtD
Phenylephrine—Skin necrosis—Etoposide—sarcoma	0.0279	0.0279	CcSEcCtD
Phenylephrine—Epigastric pain—Mitoxantrone—sarcoma	0.0242	0.0242	CcSEcCtD
Phenylephrine—Skin necrosis—Epirubicin—sarcoma	0.0156	0.0156	CcSEcCtD
Phenylephrine—Extravasation—Thiotepa—sarcoma	0.0155	0.0155	CcSEcCtD
Phenylephrine—Extravasation—Dactinomycin—sarcoma	0.0154	0.0154	CcSEcCtD
Phenylephrine—Sensitisation—Epirubicin—sarcoma	0.0153	0.0153	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Mitoxantrone—sarcoma	0.0146	0.0146	CcSEcCtD
Phenylephrine—Skin necrosis—Doxorubicin—sarcoma	0.0145	0.0145	CcSEcCtD
Phenylephrine—Sensitisation—Doxorubicin—sarcoma	0.0141	0.0141	CcSEcCtD
Phenylephrine—Extravasation—Vincristine—sarcoma	0.0138	0.0138	CcSEcCtD
Phenylephrine—Extravasation—Mitoxantrone—sarcoma	0.0134	0.0134	CcSEcCtD
Phenylephrine—Skin exfoliation—Thiotepa—sarcoma	0.0129	0.0129	CcSEcCtD
Phenylephrine—Photophobia—Thiotepa—sarcoma	0.0127	0.0127	CcSEcCtD
Phenylephrine—Pulmonary oedema—Thiotepa—sarcoma	0.0121	0.0121	CcSEcCtD
Phenylephrine—Extravasation—Etoposide—sarcoma	0.0112	0.0112	CcSEcCtD
Phenylephrine—Skin exfoliation—Etoposide—sarcoma	0.0093	0.0093	CcSEcCtD
Phenylephrine—Lacrimation—Epirubicin—sarcoma	0.00929	0.00929	CcSEcCtD
Phenylephrine—Lacrimation—Doxorubicin—sarcoma	0.00859	0.00859	CcSEcCtD
Phenylephrine—Keratitis—Epirubicin—sarcoma	0.00842	0.00842	CcSEcCtD
Phenylephrine—Keratitis—Doxorubicin—sarcoma	0.00779	0.00779	CcSEcCtD
Phenylephrine—Abdominal pain upper—Mitoxantrone—sarcoma	0.00777	0.00777	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Epirubicin—sarcoma	0.00738	0.00738	CcSEcCtD
Phenylephrine—Sweating increased—Mitoxantrone—sarcoma	0.00716	0.00716	CcSEcCtD
Phenylephrine—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00683	0.00683	CcSEcCtD
Phenylephrine—Stinging—Epirubicin—sarcoma	0.00674	0.00674	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Vincristine—sarcoma	0.00663	0.00663	CcSEcCtD
Phenylephrine—Myocardial infarction—Vincristine—sarcoma	0.0066	0.0066	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00646	0.00646	CcSEcCtD
Phenylephrine—Myocardial infarction—Mitoxantrone—sarcoma	0.00642	0.00642	CcSEcCtD
Phenylephrine—Cardiac disorder—Thiotepa—sarcoma	0.00632	0.00632	CcSEcCtD
Phenylephrine—Extravasation—Epirubicin—sarcoma	0.00626	0.00626	CcSEcCtD
Phenylephrine—Stinging—Doxorubicin—sarcoma	0.00624	0.00624	CcSEcCtD
Phenylephrine—Angiopathy—Thiotepa—sarcoma	0.00618	0.00618	CcSEcCtD
Phenylephrine—Immune system disorder—Thiotepa—sarcoma	0.00615	0.00615	CcSEcCtD
Phenylephrine—Mediastinal disorder—Thiotepa—sarcoma	0.00614	0.00614	CcSEcCtD
Phenylephrine—Arrhythmia—Thiotepa—sarcoma	0.00609	0.00609	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Epirubicin—sarcoma	0.00605	0.00605	CcSEcCtD
Phenylephrine—Bradycardia—Mitoxantrone—sarcoma	0.00599	0.00599	CcSEcCtD
Phenylephrine—Mental disorder—Thiotepa—sarcoma	0.00597	0.00597	CcSEcCtD
Phenylephrine—Sweating increased—Etoposide—sarcoma	0.00595	0.00595	CcSEcCtD
Phenylephrine—Lacrimation increased—Epirubicin—sarcoma	0.00593	0.00593	CcSEcCtD
Phenylephrine—Tension—Thiotepa—sarcoma	0.00582	0.00582	CcSEcCtD
Phenylephrine—Extravasation—Doxorubicin—sarcoma	0.00579	0.00579	CcSEcCtD
Phenylephrine—Nervousness—Thiotepa—sarcoma	0.00576	0.00576	CcSEcCtD
Phenylephrine—Atrioventricular block—Epirubicin—sarcoma	0.00563	0.00563	CcSEcCtD
Phenylephrine—Cardiac disorder—Vincristine—sarcoma	0.00561	0.00561	CcSEcCtD
Phenylephrine—Ventricular extrasystoles—Doxorubicin—sarcoma	0.00559	0.00559	CcSEcCtD
Phenylephrine—Vision blurred—Thiotepa—sarcoma	0.00559	0.00559	CcSEcCtD
Phenylephrine—Neck pain—Epirubicin—sarcoma	0.00553	0.00553	CcSEcCtD
Phenylephrine—Lacrimation increased—Doxorubicin—sarcoma	0.00548	0.00548	CcSEcCtD
Phenylephrine—Angiopathy—Vincristine—sarcoma	0.00548	0.00548	CcSEcCtD
Phenylephrine—Agitation—Thiotepa—sarcoma	0.00545	0.00545	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vincristine—sarcoma	0.00544	0.00544	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Etoposide—sarcoma	0.00537	0.00537	CcSEcCtD
Phenylephrine—Myocardial infarction—Etoposide—sarcoma	0.00534	0.00534	CcSEcCtD
Phenylephrine—Mental disorder—Vincristine—sarcoma	0.00529	0.00529	CcSEcCtD
Phenylephrine—Arrhythmia—Mitoxantrone—sarcoma	0.00525	0.00525	CcSEcCtD
Phenylephrine—Skin exfoliation—Epirubicin—sarcoma	0.00521	0.00521	CcSEcCtD
Phenylephrine—Atrioventricular block—Doxorubicin—sarcoma	0.00521	0.00521	CcSEcCtD
Phenylephrine—Hypertension—Thiotepa—sarcoma	0.00512	0.00512	CcSEcCtD
Phenylephrine—Neck pain—Doxorubicin—sarcoma	0.00511	0.00511	CcSEcCtD
Phenylephrine—Dysgeusia—Mitoxantrone—sarcoma	0.00501	0.00501	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00501	0.00501	CcSEcCtD
Phenylephrine—Pulmonary oedema—Epirubicin—sarcoma	0.00486	0.00486	CcSEcCtD
Phenylephrine—Agitation—Vincristine—sarcoma	0.00483	0.00483	CcSEcCtD
Phenylephrine—Vision blurred—Mitoxantrone—sarcoma	0.00483	0.00483	CcSEcCtD
Phenylephrine—Skin exfoliation—Doxorubicin—sarcoma	0.00482	0.00482	CcSEcCtD
Phenylephrine—Nervous system disorder—Thiotepa—sarcoma	0.00475	0.00475	CcSEcCtD
Phenylephrine—Tachycardia—Thiotepa—sarcoma	0.00472	0.00472	CcSEcCtD
Phenylephrine—Skin disorder—Thiotepa—sarcoma	0.0047	0.0047	CcSEcCtD
Phenylephrine—Cardiac disorder—Etoposide—sarcoma	0.00454	0.00454	CcSEcCtD
Phenylephrine—Hypertension—Vincristine—sarcoma	0.00454	0.00454	CcSEcCtD
Phenylephrine—Pulmonary oedema—Doxorubicin—sarcoma	0.0045	0.0045	CcSEcCtD
Phenylephrine—Angiopathy—Etoposide—sarcoma	0.00444	0.00444	CcSEcCtD
Phenylephrine—Hypertension—Mitoxantrone—sarcoma	0.00442	0.00442	CcSEcCtD
Phenylephrine—Immune system disorder—Etoposide—sarcoma	0.00442	0.00442	CcSEcCtD
Phenylephrine—Mediastinal disorder—Etoposide—sarcoma	0.00441	0.00441	CcSEcCtD
Phenylephrine—Eye pain—Epirubicin—sarcoma	0.00439	0.00439	CcSEcCtD
Phenylephrine—Chest pain—Mitoxantrone—sarcoma	0.00436	0.00436	CcSEcCtD
Phenylephrine—Paraesthesia—Thiotepa—sarcoma	0.00435	0.00435	CcSEcCtD
Phenylephrine—Nervous system disorder—Vincristine—sarcoma	0.00421	0.00421	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00418	0.00418	CcSEcCtD
Phenylephrine—Dysgeusia—Etoposide—sarcoma	0.00417	0.00417	CcSEcCtD
Phenylephrine—Hyperhidrosis—Vincristine—sarcoma	0.00415	0.00415	CcSEcCtD
Phenylephrine—Pain—Thiotepa—sarcoma	0.00414	0.00414	CcSEcCtD
Phenylephrine—Shock—Mitoxantrone—sarcoma	0.00411	0.00411	CcSEcCtD
Phenylephrine—Pain—Dactinomycin—sarcoma	0.00411	0.00411	CcSEcCtD
Phenylephrine—Tachycardia—Mitoxantrone—sarcoma	0.00408	0.00408	CcSEcCtD
Phenylephrine—Eye pain—Doxorubicin—sarcoma	0.00406	0.00406	CcSEcCtD
Phenylephrine—Skin disorder—Mitoxantrone—sarcoma	0.00406	0.00406	CcSEcCtD
Phenylephrine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00404	0.00404	CcSEcCtD
Phenylephrine—Paraesthesia—Vincristine—sarcoma	0.00385	0.00385	CcSEcCtD
Phenylephrine—Urticaria—Thiotepa—sarcoma	0.00384	0.00384	CcSEcCtD
Phenylephrine—Paraesthesia—Mitoxantrone—sarcoma	0.00375	0.00375	CcSEcCtD
Phenylephrine—Loss of consciousness—Etoposide—sarcoma	0.00374	0.00374	CcSEcCtD
Phenylephrine—Dyspnoea—Mitoxantrone—sarcoma	0.00373	0.00373	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vincristine—sarcoma	0.0037	0.0037	CcSEcCtD
Phenylephrine—Hypertension—Etoposide—sarcoma	0.00368	0.00368	CcSEcCtD
Phenylephrine—Pain—Vincristine—sarcoma	0.00367	0.00367	CcSEcCtD
Phenylephrine—Chest pain—Etoposide—sarcoma	0.00363	0.00363	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—sarcoma	0.00362	0.00362	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—sarcoma	0.00362	0.00362	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.0036	0.0036	CcSEcCtD
Phenylephrine—Pain—Mitoxantrone—sarcoma	0.00357	0.00357	CcSEcCtD
Phenylephrine—Hypersensitivity—Thiotepa—sarcoma	0.00357	0.00357	CcSEcCtD
Phenylephrine—Hypersensitivity—Dactinomycin—sarcoma	0.00354	0.00354	CcSEcCtD
Phenylephrine—Pruritus—Thiotepa—sarcoma	0.00342	0.00342	CcSEcCtD
Phenylephrine—Tachycardia—Etoposide—sarcoma	0.00339	0.00339	CcSEcCtD
Phenylephrine—Skin disorder—Etoposide—sarcoma	0.00338	0.00338	CcSEcCtD
Phenylephrine—Hyperhidrosis—Etoposide—sarcoma	0.00336	0.00336	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Phenylephrine—Urticaria—Mitoxantrone—sarcoma	0.00332	0.00332	CcSEcCtD
Phenylephrine—Dizziness—Thiotepa—sarcoma	0.0032	0.0032	CcSEcCtD
Phenylephrine—Hypersensitivity—Vincristine—sarcoma	0.00316	0.00316	CcSEcCtD
Phenylephrine—Paraesthesia—Etoposide—sarcoma	0.00312	0.00312	CcSEcCtD
Phenylephrine—Dyspnoea—Etoposide—sarcoma	0.0031	0.0031	CcSEcCtD
Phenylephrine—Hypersensitivity—Mitoxantrone—sarcoma	0.00308	0.00308	CcSEcCtD
Phenylephrine—Vomiting—Thiotepa—sarcoma	0.00308	0.00308	CcSEcCtD
Phenylephrine—Vomiting—Dactinomycin—sarcoma	0.00305	0.00305	CcSEcCtD
Phenylephrine—Rash—Thiotepa—sarcoma	0.00305	0.00305	CcSEcCtD
Phenylephrine—Dermatitis—Thiotepa—sarcoma	0.00305	0.00305	CcSEcCtD
Phenylephrine—Headache—Thiotepa—sarcoma	0.00303	0.00303	CcSEcCtD
Phenylephrine—Rash—Dactinomycin—sarcoma	0.00303	0.00303	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Etoposide—sarcoma	0.003	0.003	CcSEcCtD
Phenylephrine—Pain—Etoposide—sarcoma	0.00297	0.00297	CcSEcCtD
Phenylephrine—Nausea—Thiotepa—sarcoma	0.00287	0.00287	CcSEcCtD
Phenylephrine—Nausea—Dactinomycin—sarcoma	0.00285	0.00285	CcSEcCtD
Phenylephrine—Dizziness—Vincristine—sarcoma	0.00284	0.00284	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Phenylephrine—Urticaria—Etoposide—sarcoma	0.00276	0.00276	CcSEcCtD
Phenylephrine—Vomiting—Vincristine—sarcoma	0.00273	0.00273	CcSEcCtD
Phenylephrine—Rash—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Phenylephrine—Dermatitis—Vincristine—sarcoma	0.0027	0.0027	CcSEcCtD
Phenylephrine—Headache—Vincristine—sarcoma	0.00269	0.00269	CcSEcCtD
Phenylephrine—Vomiting—Mitoxantrone—sarcoma	0.00266	0.00266	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Phenylephrine—Rash—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Phenylephrine—Dermatitis—Mitoxantrone—sarcoma	0.00263	0.00263	CcSEcCtD
Phenylephrine—Headache—Mitoxantrone—sarcoma	0.00262	0.00262	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Phenylephrine—Hypersensitivity—Etoposide—sarcoma	0.00256	0.00256	CcSEcCtD
Phenylephrine—Nausea—Vincristine—sarcoma	0.00255	0.00255	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Phenylephrine—Nausea—Mitoxantrone—sarcoma	0.00248	0.00248	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Phenylephrine—Pruritus—Etoposide—sarcoma	0.00246	0.00246	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—sarcoma	0.00245	0.00245	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Phenylephrine—Tension—Epirubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Phenylephrine—Dizziness—Etoposide—sarcoma	0.0023	0.0023	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Phenylephrine—Vomiting—Etoposide—sarcoma	0.00221	0.00221	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Phenylephrine—Rash—Etoposide—sarcoma	0.00219	0.00219	CcSEcCtD
Phenylephrine—Dermatitis—Etoposide—sarcoma	0.00219	0.00219	CcSEcCtD
Phenylephrine—Headache—Etoposide—sarcoma	0.00218	0.00218	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—sarcoma	0.00217	0.00217	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Phenylephrine—Nausea—Etoposide—sarcoma	0.00206	0.00206	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Phenylephrine—Shock—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Phenylephrine—Pain—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Phenylephrine—Rash—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Phenylephrine—Headache—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
